Metformin synergistically enhances the antitumour activity of Lenvatinib in hepatocellular carcinoma by altering AKT-FOXO3 signalling pathway.
LIVER INTERNATIONAL（2023）
摘要
The Lenvatinib-Metformin combination may provide a potential therapeutic strategy to improve the prognosis of HCC patients.
更多查看译文
关键词
AKT,combination,FOXO3,Lenvatinib,metformin
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要